Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IM Cannabis Corp. (IMCC : NSDQ)
 
 • Company Description   
IM Cannabis Corp. is an MCO in the medical and adult-use recreational cannabis sector. It operates principally in Israel, Germany and Canada. IM Cannabis Corp. is headquartered in Israel.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.02 Daily Weekly Monthly
20 Day Moving Average: 205,099 shares
Shares Outstanding: 69.69 (millions)
Market Capitalization: $71.08 (millions)
Beta:
52 Week High: $6.35
52 Week Low: $0.84
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -44.56% -39.49%
12 Week -60.16% -56.94%
Year To Date -69.46% -63.83%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
KIBBUTZ GLIL YAM
-
TEL AVIV-YAFO,L3 4690500
ISR
ph: 972-54-433-1111
fax: -
maya.l@imcannabis.com http://www.imcannabis.com
 
 • General Corporate Information   
Officers
Oren Shuster - Chief Executive Officer and Director
Marc Lustig - Chairman
Shai Shemesh - Chief Financial Officer
Yael Harrosh - Director
Richard Balla - Director

Peer Information
IM Cannabis Corp. (BJCT)
IM Cannabis Corp. (CADMQ)
IM Cannabis Corp. (APNO)
IM Cannabis Corp. (UPDC)
IM Cannabis Corp. (IMTIQ)
IM Cannabis Corp. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 44969Q208
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/15/22
Share - Related Items
Shares Outstanding: 69.69
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $71.08 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.04 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.14 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/15/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 7.29
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.45
Price/Cash Flow: -
Price / Sales: 1.29
EPS Growth
vs. Year Ago Period: -160.00%
vs. Previous Quarter: 13.33%
Sales Growth
vs. Year Ago Period: 168.77%
vs. Previous Quarter: 16.61%
ROE
03/31/22 - -16.28
12/31/21 - -10.04
09/30/21 - -19.57
ROA
03/31/22 - -11.82
12/31/21 - -7.32
09/30/21 - -14.00
Current Ratio
03/31/22 - 1.47
12/31/21 - 1.65
09/30/21 - 2.29
Quick Ratio
03/31/22 - 0.88
12/31/21 - 1.04
09/30/21 - 1.50
Operating Margin
03/31/22 - -44.71
12/31/21 - -31.34
09/30/21 - -60.79
Net Margin
03/31/22 - -44.71
12/31/21 - -31.34
09/30/21 - -60.79
Pre-Tax Margin
03/31/22 - -49.37
12/31/21 - -33.17
09/30/21 - -
Book Value
03/31/22 - 2.25
12/31/21 - 2.40
09/30/21 - 2.50
Inventory Turnover
03/31/22 - 2.05
12/31/21 - 1.88
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.09
12/31/21 - 0.09
09/30/21 - 0.08
Debt-to-Capital
03/31/22 - 8.17
12/31/21 - 8.16
09/30/21 - 7.58
 

Powered by Zacks Investment Research ©